VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 487 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2014. The put-call ratio across all filers is 0.91 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $6,000 | -62.5% | 500 | -54.5% | 0.00% | -100.0% |
| Q4 2016 | $16,000 | -36.0% | 1,100 | +10.0% | 0.00% | 0.0% |
| Q3 2016 | $25,000 | -71.9% | 1,000 | +100.0% | 0.00% | -80.0% |
| Q3 2015 | $89,000 | -19.8% | 500 | 0.0% | 0.01% | -16.7% |
| Q2 2015 | $111,000 | +12.1% | 500 | 0.0% | 0.01% | +20.0% |
| Q1 2015 | $99,000 | +73.7% | 500 | +25.0% | 0.01% | +66.7% |
| Q4 2014 | $57,000 | +9.6% | 400 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $52,000 | +4.0% | 400 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $50,000 | +25.0% | 400 | +33.3% | 0.00% | +50.0% |
| Q1 2014 | $40,000 | -57.4% | 300 | -62.5% | 0.00% | -60.0% |
| Q4 2013 | $94,000 | +13.3% | 800 | 0.0% | 0.01% | 0.0% |
| Q3 2013 | $83,000 | +93.0% | 800 | +60.0% | 0.01% | +66.7% |
| Q2 2013 | $43,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |